*Some Market data delayed by 15 mins.

Spero Therapeutics, Inc. Common Stock

Symbol: SPRO (NASDAQ)
1.97 ▲ (4.52%) 0.085

Company Description:
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Key Stats
  • Today's Open: $1.89
  • Today's High: $1.969
  • Today's Low: $1.862
  • Today's Volume: 221.93K
  • Yesterday Close: $1.88
  • Yesterday High: $1.91
  • Yesterday Low: $1.84
  • Yesterday Volume: 385.87K
  • Last Min Volume: 300
  • Last Min High: $1.969
  • Last Min Low: $1.966
  • Last Min VWAP: $1.967
Company Profile
  • Name: Spero Therapeutics, Inc. Common Stock
  • Website: https://www.sperotherapeutics.com
  • Listed Date: 2017-11-02
  • Location: CAMBRIDGE, MA
  • Market Status: Active
  • CIK Number: 0001701108
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $105.80M
  • Round Lot: 100
  • Outstanding Shares: 56.28M
  • Asset Type: CS
RECENT FILINGS FOR SPRO
Filing Date Filing Type Format
2025-09-03 4 View
2025-09-03 4 View
2025-08-14 SCHEDULE 13G/A View
2025-08-12 S-8 View
2025-08-12 10-Q View
2025-08-12 8-K View
2025-06-18 8-K View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-05-28 8-K View
2025-05-13 8-K View
2025-05-13 10-Q View
2025-05-06 4 View
2025-04-28 ARS View
Latest News on SPRO

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.